Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations
NCT00334711
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Diabetes Mellitus
Interventions
DRUG:
Sulfonylurea
Sponsor
Royal Devon and Exeter NHS Foundation Trust
Collaborators
[object Object]
[object Object]
[object Object]